D. Griswold

发表

The soluble form of E-selectin is an asymmetric monomer. Expression, purification, and characterization of the recombinant protein.

K. Kopple, J. Trill, D. Mcnulty, 1994, The Journal of biological chemistry.

Anti-TNF-α antibody allows healing of joint damage in polyarthritic transgenic mice

D. Shealy, Xiao-yu R. Song, A. Rosenberg, 2002, Arthritis research.

Expression and activation of the oxytocin receptor in airway smooth muscle cells: Regulation by TNFα and IL-13

C. Brightling, P. Cooper, F. Syed, 2010, Respiratory research.

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.

John C. Lee, J. Adams, J. Adams, 2000, American journal of physiology. Lung cellular and molecular physiology.

SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.

S. Christensen, A. Badger, S. Christensen, 1998, The Journal of pharmacology and experimental therapeutics.

Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730).

E. F. Smith, R. Smith, J. Egan, 1993, European journal of pharmacology.

Coming of age: anti-cytokine therapies.

D. Shealy, Xiao-yu R. Song, T. Torphy, 2002, Molecular interventions.

Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration*

R. Hertzberg, H. Sarau, J. Foley, 1998, The Journal of Biological Chemistry.

Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis

D. Griswold, E. Webb, L. Hillegass, 1991, Inflammation.

Subject Index, Vol. 44, 1992

J. Catravas, I. Ehrhart, N. Kaplowitz, 1992 .

Reperfusion Increases Neutrophils and Leukotriene B4 Receptor Binding in Rat Focal Ischemia

H. Sarau, F. Barone, G. Feuerstein, 1992, Stroke.

Inflammatory mediators of experimental colitis in rats.

L. Schwartz, P. Simon, D. Rachmilewitz, 1989, Gastroenterology.

Conjunctival leukocyte infiltration evoked by leukotrienes: differing responses among rodent species.

D. Griswold, S. J. Newsholme, L. Schwartz, 1994, Journal of lipid mediators and cell signalling.

Beta-lactams SB 212047 and SB 216754 are irreversible, time-dependent inhibitors of coenzyme A-independent transacylase.

R. Mayer, L. Marshall, F. Chilton, 1998, Molecular pharmacology.

5 – Inhibitors of Fatty Acid-Derived Mediators

D. Hay, D. Griswold, 1994 .

Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses.

J. Lee, D. Maley, D. Cassatt, 1994, International journal of immunopharmacology.

1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.

J. Boehm, J. Adams, T. Gallagher, 1996, Journal of medicinal chemistry.

Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.

Li Li, J. Radewonuk, E. Emmell, 2006, Cellular immunology.

Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli.

P. Young, S. Kumar, D. Griswold, 1997, Biochemical and biophysical research communications.

Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissue.

E. Smith, J. Egan, D. Hill, 1988, Journal of pharmacological methods.

Evaluation of the effect of evan's blue and triphenyltetrazolium chloride dyes on myeloperoxidase activity in canine cardiac tissue.

D. Hill, D. Griswold, G. Kopia, 1989, Journal of pharmacological methods.

Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.

T. Yue, G. Feuerstein, J. Hallenbeck, 1991, Circulation research.

Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.

J. Boehm, S. Kassis, J. Adams, 1998, Bioorganic & medicinal chemistry letters.

What's in the pipeline? Prospects for monoclonal antibodies (mAbs) as therapies for lung diseases.

T. Torphy, Li Li, D. Griswold, 2002, Pulmonary pharmacology & therapeutics.

Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling.

Jian Li, Li Li, D. Shealy, 2004, Cytokine.

Therapeutic Dosing with Anti-Interleukin-13 Monoclonal Antibody Inhibits Asthma Progression in Mice

P. Bugelski, T. Petley, Li Li, 2005, Journal of Pharmacology and Experimental Therapeutics.

Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic.

S. Christensen, R. Nieman, D. Underwood, 1999, Pulmonary pharmacology & therapeutics.

Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.

H. Sarau, J. Foley, F. Barone, 2002, The Journal of pharmacology and experimental therapeutics.

Evaluation of the cutaneous anti-inflammatory activity of azaspiranes

A. Badger, D. Griswold, J. Breton, 1998, Inflammation Research.

Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.

M. Slivjak, E. Smith, J. Egan, 1989, Prostaglandins.

Temporal relation between neutrophil accumulation and myocardial reperfusion injury.

E. Smith, P. Bugelski, J. Egan, 1988, The American journal of physiology.

Protection against Lipopolysaccharide-induced Death by An Anti-Interleukin-6 Monoclonal Antibody

Xiao-yu R. Song, D. Griswold, B. Liang, 2007 .

IL-4 and IL-13 Form a Negative Feedback Circuit with Surfactant Protein-D in the Allergic Airway Response1

K. Chung, E. Crouch, A. Haczku, 2006, The Journal of Immunology.

Circuit with Surfactant Protein-D in the IL-4 and IL-13 Form a Negative Feedback

K. Chung, A. Haczku, S. Hawgood, 2006 .

IL-4 and IL-13 Form a Negative Feedback Circuit with Surfactant Protein-D in the Allergic Airway Response 1

K. Chung, E. Crouch, A. Haczku, 2006 .

Interleukin-8 Receptor (CXCR2) Antagonists

H. Sarau, Surname, J. R. White, 2001 .

Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor.

J. D. Elliott, D. Veber, R. Hertzberg, 2004, Journal of medicinal chemistry.

Monoclonal antibodies as a strategy for pulmonary diseases.

T. Torphy, D. Griswold, L. Li, 2001, Current opinion in pharmacology.

The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6.

S. Rennard, M. Hashimoto, S. Abe, 2007, American journal of respiratory cell and molecular biology.

IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gamma-deficient mice in a Th2-biased response.

L. Li, J. Radewonuk, E. Emmell, 2006, Cellular immunology.

Regulation of antigen-specific versus by-stander IgE production after antigen sensitization.

L. Li, G. Yang, E. Emmell, 2004, Cellular immunology.

Role of complement in endotoxin/platelet-activating factor-induced lung injury.

G. Feuerstein, R. Rabinovici, J. Vernick, 1992, Journal of immunology.

Phlogistic activity of leukotriene D4 in the mouse

M. A. Clark, S. Mong, D. Griswold, 1986, Inflammation.

Inhibition of p38 MAP Kinase

D. Underwood, D. Griswold, 2001 .

Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase

G. Poste, N. Hanna, D. Griswold, 1987, Agents and Actions.

SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.

H. Sarau, G. Poste, J. Gleason, 1987, Biochemical pharmacology.

Stimulation of hemolysin plaque-forming cells by idoxuridine.

G. Heppner, P. Calabresi, D. Griswold, 1975, Cancer research.

Constitutive Cyclooxygenase (COX-1) and Inducible Cyclooxygenase (COX- 2): Rationale for Selective Inhibition and Progress to Date

J. Adams, D. Griswold, 1996 .

Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.

H. Sarau, J. Foley, F. Barone, 2000, The Journal of pharmacology and experimental therapeutics.

In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.

H. Sarau, J. Foley, S. Van Horn, 1999, Prostaglandins, leukotrienes, and essential fatty acids.

Pharmacological evaluation of leukotriene biosynthesis and inflammation in an adoptive model of peritoneal anaphylaxis in the mouse

J. R. White, D. Griswold, L. Hillegass, 1993 .

Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family*

M. Doyle, R. Tal-Singer, P. Young, 2000, The Journal of Biological Chemistry.

Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists.

G. Poste, A. Badger, N. Hanna, 1984, Journal of immunology.

Immunopharmacology of gold sodium thiomalate and auranofin (SK&F D-39162)

D. Griswold, D. T. Walz, 1978, Inflammation.

Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole

D. Griswold, D. T. Walz, 1978, Inflammation.

Condition-dependent immunoregulatory control of contact sensitivity by levamisole

D. Griswold, D. T. Walz, 1977, Inflammation.

Inhibition of carrageenan-induced inflammation by urethan anesthesia in adrenalectomized and sham-operated rats.

D. Griswold, D. T. Walz, E. Webb, 1982, Journal of pharmacological methods.

Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493

P. Bender, S. Hoffstein, N. Hanna, 1989, Inflammation.

Arachidonic acid-induced inflammation: Inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002

N. Hanna, D. Griswold, E. Webb, 1987, Inflammation.

Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.

H. Sarau, J. Lee, P. Bender, 1991, Biochemical pharmacology.

Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.

J. Lee, N. Hanna, D. Griswold, 1991, Biochemical pharmacology.

Technique for quantification of LTB4-induced changes in peripheral granulocyte counts in vivo in the rabbit.

L. Meunier, J. Ventre, D. Griswold, 1991, Journal of pharmacological methods.

Use of a continuous assay of oxygen consumption to evaluate the pharmacology of 5-lipoxygenase inhibitors.

W. deWolf, D. Griswold, J. Breton, 1993, Prostaglandins, leukotrienes, and essential fatty acids.

Selective alteration of immunocompetence with methotrexate and 5-fluorouracil.

P. Calabresi, D. Griswold, J. DiLorenzo, 1974, Cancer research.

PGE2 and IL‐6 production by fibroblasts in response to titanium wear debris particles is mediated through a Cox‐2 dependent pathway

E. Schwarz, J. Puzas, R. O’Keefe, 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.

B. Scallon, Li Li, J. Carton, 2006, International immunopharmacology.

Inhibition of p38 MAP kinase as a therapeutic strategy.

D E Griswold, John C. Lee, J. Adams, 2000, Immunopharmacology.

(E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.

H. Sarau, J. Foley, K. Sham, 1996, Journal of medicinal chemistry.

Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.

M. Slivjak, P. Davis, D. Griswold, 1992, Pharmacology.

Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.

J. Egan, D. Griswold, Edward F Smith, 1989, Pharmacology.

Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation.

H. Davis, D. Griswold, D. Carpenter, 2000, Journal of immunological methods.

Quantitative Western blot assay for measurement of the murine acute phase reactant, serum amyloid P component.

N. Hanna, D. Griswold, L. Antell, 1986, Journal of immunological methods.

Augmentation of concanavalin A-induced immunosuppression by indomethacin.

A. Badger, D. Griswold, D. T. Walz, 1982, Immunopharmacology.

Interleukin-8 production is regulated by protein kinase C in human keratinocytes.

J. Lee, D. Griswold, J. Breton, 1994, The Journal of investigative dermatology.

Induction of suppressor cells, interleukin-2 production and mitogenesis with monomeric concanavalin A: different actions of tetrameric and monomeric concanavalin A.

G. Poste, P. Bender, N. Hanna, 1985, Molecular immunology.

Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis.

A. Badger, S. Hoffman, B. Swift, 1999, The Journal of pharmacology and experimental therapeutics.

Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.

E. Smith, J. Egan, D. Griswold, 1989, Progress in clinical and biological research.

Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response

J. R. White, T. Torphy, D. Griswold, 1993, Inflammation.

Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4‐specific monoclonal antibodies: CD4+ T‐cell depletion is not required

P. Podolin, A. Truneh, D. Griswold, 2000, Immunology.

Selective inhibition of 5-lipoxygenase attenuates glomerulonephritis in the rat.

J. Adams, D. Griswold, G. Dytko, 1994, Kidney international.

Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.

J. Boehm, S. Kassis, J. Adams, 2001, Bioorganic & medicinal chemistry letters.

H. Sarau, J. Foley, F. Barone, 1995, Molecular and chemical neuropathology.

1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.

J. Boehm, J. Adams, T. Gallagher, 1996, Journal of medicinal chemistry.

2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis

Jerry L. Adams, John C. Lee, J. Adams, 1995 .

1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma.

S. Christensen, P. Bender, J. Bartus, 1998, Journal of medicinal chemistry.

Bicyclic N-hydroxyurea inhibitors of 5-lipoxygenase: pharmacodynamic, pharmacokinetic, and in vitro metabolic studies characterizing N-hydroxy-N-(2,3-dihydro-6-(phenylmethoxy)-3-benzofuranyl)urea.

J. Adams, R. Garigipati, L. A. Yodis, 1996, Journal of medicinal chemistry.

Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.

D E Griswold, J. Boehm, S. Kassis, 1998, Bioorganic & medicinal chemistry letters.

Synthesis, X‐ray crystal structure determination and antiinflammatory activity of the regioisomers: 5‐phenyl‐6‐(4‐pyridyl)‐2,3‐dihydroimidazo[2,1‐b]thiazole and 6‐phenyl‐5‐(4‐pyridyl)‐2,3‐dihydroimidazo[2,1‐b]thiazole. A structural reassignment

P. Bender, D. Eggleston, S. Shilcrat, 1991 .

Biologic actions and pharmacokinetic studies of auranofin.

D E Griswold, T. Flanagan, D T Walz, 1983, The American journal of medicine.

Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.

D. Griswold, D. T. Walz, M. Dimartino, 1980, The Journal of rheumatology.

5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agents.

P. Bender, P. Lavanchy, P. Offen, 1985, Journal of medicinal chemistry.

Antiinflammatory activity of topical auranofin in arachidonic acid‐ and phorbol ester‐induced inflammation in mice

D. Griswold, E. Webb, L. Hillegass, 1995 .

Mechanisms of action of auranofin: effects on humoral immune response.

D. Griswold, D. T. Walz, M. Dimartino, 1982, The Journal of rheumatology. Supplement.

Comparative pharmacology and biological effects of different gold compounds.

D. Griswold, D. T. Walz, M. Dimartino, 1982, The Journal of rheumatology. Supplement.

Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.

D. Griswold, D. T. Walz, M. Dimartino, 1979, The Journal of rheumatology. Supplement.

Distribution of gold in blood following administration of auranofin (SK&F D-39162).

D. Griswold, D. T. Walz, M. Dimartino, 1979, The Journal of rheumatology. Supplement.

Bis(triethylphosphine)gold(I) chloride: ionization in aqueous solution, reduction in vitro of the external and internal disulfide bonds of bovine serum albumin, and antiarthritic activity

A. Isab, C. Shaw, D. Griswold, 1989 .

Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002.

J. Lee, N. Hanna, B. Votta, 1988, International journal of immunopharmacology.

Assessment of myeloperoxidase activity in whole rat kidney.

D E Griswold, L M Hillegass, B Brickson, 1990, Journal of pharmacological methods.

Antiinflammatory activity of 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles. Isomeric 4-pyridyl and 4-substituted phenyl derivatives.

P. Bender, I. Lantos, D. Griswold, 1984, Journal of medicinal chemistry.

Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progression.

A. Badger, P. Bugelski, B. Swift, 1993, International journal of immunopharmacology.

Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist.

H. Sarau, J. Foley, N. Elshourbagy, 1997, The Journal of pharmacology and experimental therapeutics.

In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non‐peptide NK3 receptor antagonists

A. A. Parsons, A. Medhurst, D. Hay, 1997, British journal of pharmacology.

Identification of live cells for flow cytometric analysis of lymphoid subset proliferation in low viability populations.

D. Griswold, L. Antell, E. Kloszewski, 1985, Journal of immunological methods.

Selective suppression of humoral and cellular immunity with cytosine arabinoside.

G. Heppner, P. Calabresi, D. Griswold, 1972, Cancer research.

Immunosuppressant effect of salicylate and quinine on antibody forming cells.

D. Griswold, E. Uyeki, 1969, European journal of pharmacology.

Correction of a murine mammary tumor virus-associated immunological depression by selective immunosuppression with cytosine arabinoside.

G. Heppner, D. Griswold, J. Manning, 1975, Cancer Research.

Quantification and pharmacological dissection of oxazolone-induced contact sensitivity in the mouse.

P. Calabresi, D. Griswold, J. DiLorenzo, 1974, Cellular immunology.

Synergism of Methotrexate with 1muran and with 5-Fluorouracil and Their Effects on Hemolysin Plaque-forming Cell Production in the Mouse1

P. Calabresi, D. Griswold, C. Bareham, 2006 .

Synergism of Methotrexate with 1 muran and with 5-Fluorouracil and Their Effects on Hemolysin Plaque-forming Cell Production in the Mouse 1

P. Calabresi, D. Griswold, C. Bareham, 2006 .

Synergism of methotrexate with imuran and with 5-fluorouracil and their effects on hemolysin plaque-forming cell production in the mouse.

P. Calabresi, D. Griswold, C. Bareham, 1974, Cancer research.

Selective immunosuppression by drugs in balanced immune responses.

G. Heppner, P. Calabresi, E. Poplin, 1974, Federation proceedings.

Alteration of immunocompetence by mammary tumor virus.

G. Heppner, P. Calabresi, D. Griswold, 1973, Journal of the National Cancer Institute.

Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.

J. Boehm, John C. Lee, J. Adams, 2000, Arthritis and rheumatism.

Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4.

D. Griswold, E. Webb, S. J. Newsholme, 1998, The Journal of investigative dermatology.

SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.

R R Osborn, D E Griswold, J. Adams, 2000, The Journal of pharmacology and experimental therapeutics.

Activation of the IL-1 gene in UV-irradiated mouse skin: association with inflammatory sequelae and pharmacologic intervention.

J. Lee, N. Hanna, J. Connor, 1991, The Journal of investigative dermatology.

Microprocessor-assisted plethysmograph for the measurement of mouse paw volume.

D. Griswold, E. Webb, 1984, Journal of pharmacological methods.

Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.

D E Griswold, John C. Lee, J. Adams, 1996, The Journal of pharmacology and experimental therapeutics.

Effect of selected immunoregulatory agents on low-grade contact sensitivity

D. Griswold, D. T. Walz, 1982, Inflammation.

The pharmacological profile of auranofin, an orally active gold compound.

D. Griswold, D. T. Walz, M. Dimartino, 1983, Scandinavian journal of rheumatology. Supplement.

Long-term activation of TLR3 by Poly(I:C) induces inflammation and impairs lung function in mice

R. Flavell, M. Mbow, R. Sarisky, 2009, Respiratory research.

Dermokine: an extensively differentially spliced gene expressed in epithelial cells.

M. D'Andrea, B. Amegadzie, Xiao-yu R. Song, 2007, The Journal of investigative dermatology.

Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models.

S. Kassis, J. Adams, J. Jackson, 1998, The Journal of pharmacology and experimental therapeutics.

Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification

H. Sarau, F. Barone, G. Feuerstein, 1991, Journal of neuroscience research.

Bicyclic Imidazoles as a Novel Class of Cytokine Biosynthesis Inhibitors

P. Bender, A. Badger, J. R. White, 1993, Annals of the New York Academy of Sciences.

Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis.

N. Hanna, P. Meunier, D. Griswold, 1988, Arthritis and rheumatism.

Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus

Xiao-yu R. Song, P. Bugelski, D. Griswold, 2006, Immunology.

Induction of dendritic cell maturation by IL-18.

M. Mbow, Li Li, D. Shealy, 2004, Cellular immunology.

Differential effects of intact subunits and nicked fragments of concanavalin A on immune functions in vitro and in vivo.

G. Poste, P. Bender, R. Sitrin, 1983, Journal of immunology.

Constitutive cyclooxygenase (COX‐1) and inducible cyclooxygenase (COX‐2): Rationale for selective inhibition and progress to date

J. Adams, D. Griswold, 1996, Medicinal research reviews.

Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.

G. Feuerstein, K. Esser, R. Rabinovici, 1993, The Journal of pharmacology and experimental therapeutics.

Inhibitory effect of SK&F 86002 on monocyte IL-1 production

J. Lee, N. Hanna, B. Votta, 1989, Agents and Actions.

Anti-CD3 antibodies OKT3 and hOKT3gamma1(Ala-Ala) induce proliferation of T cells but impair expansion of alloreactive T cells; aspecifc T cell proliferation induced by anti-CD3 antibodies correlates with impaired expansion of alloreactive T cells.

S. Popma, Li Li, D. Griswold, 2005, International immunopharmacology.

Inhibition of human monocyte IL-1 production by SK&F 86002

John C. Lee, P. Bender, N. Hanna, 1990 .

Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivo.

J. Laydon, J. Lee, T. Torphy, 1996, JIM - Journal of Immunological Methods.

Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production.

J. Adams, K. Esser, D. Griswold, 1993, Drugs under experimental and clinical research.

Fighting pulmonary fibrosis: new science brings new therapeutic opportunities

G. Laurent, C. Molloy, A. Protter, 2004 .

Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.

L. Marshall, A. Roshak, C. Sung, 1994, The Journal of pharmacology and experimental therapeutics.

Differential sensitivity of T suppressor cell expression to inhibition by histamine type 2 receptor antagonists.

G. Poste, A. Badger, N. Hanna, 1986, Journal of immunology.

1324 – Comparison of Blood and Kidney Gold (Au) Levels in Rats Treated with Orally Administered SK&F D-39162 and Parenteral Gold Sodium Thiomalate (GST)

D. Griswold, D. T. Walz, S. Alessi, 1977 .

( Clusterin ) LNCaP Cells by Overexpression of Sulfated Glycoprotein-2 in α Prevention of Cell Death Induced by Tumor Necrosis Factor

Stephen, Anthony, Michael, 2006 .

Endothelin B receptor modulates inflammatory pain and cutaneous inflammation.

Z. Ao, S. Douglas, E. Ohlstein, 1999, Molecular pharmacology.

(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist.

H. Sarau, J. Foley, D. R. Jakas, 1993, Journal of Medicinal Chemistry.

Human leukocyte reactivity to penicilloylated erythrocytes.

P. Calabresi, D. Griswold, 1974, Blood.

Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators.

L. Marshall, A. Nixon, A. Fonteh, 1995, The Journal of pharmacology and experimental therapeutics.

The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells

F. Syed, R. Panettieri, B. Amegadzie, 2005, Respiratory research.

SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.

H. Sarau, J. Foley, D. Schmidt, 1995, Advances in prostaglandin, thromboxane, and leukotriene research.

Low-molecular-weight TNF biosynthesis inhibitors: strategies and prospectives.

A. Badger, U. Prabhakar, D. Griswold, 1994, Circulatory shock.

Therapeutic intervention in a rat model of adult respiratory distress syndrome: II. Lipoxygenase pathway inhibition.

L. Schwartz, E. Wheeldon, D. Griswold, 1991, Circulatory shock.

Renal effects of cyclooxygenase inhibitors in volume-depleted dogs

J. Adams, R. Palmer, D. Brooks, 2004, InflammoPharmacology.

A high performance liquid chromatography assay for the rapid analysis of the subunit content of concanavalin A.

G. Poste, P. Bender, R. Sitrin, 1982, Biochimica et biophysica acta.

Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation.

A. Isab, B. Jones, C. Shaw, 2010, Inorganic chemistry.

Re-classification of NSAIDs.

G. Poste, T. Torphy, D. Griswold, 1997, Trends in pharmacological sciences.

Identification of interleukin-13 related biomarkers using peripheral blood mononuclear cells

F. Syed, B. Amegadzie, C. C. Huang, 2007, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice.

Z. Ao, S. Douglas, E. Ohlstein, 2000, Journal of cardiovascular pharmacology.

Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.

D. Griswold, P. Marshall, E. Webb, 1991, Agents and actions. Supplements.